[CYCC] YoY Quarter Result on 31-Dec-2016 [#Q4]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
31-Mar-2017
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- 3.63%
YoY- 15.86%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 0 150 0 277 424 247 299 -
PBT -2,752 -2,370 -2,071 -3,249 -3,872 -5,907 -4,026 -6.14%
Tax -449 -352 -200 -409 -498 -1,108 -452 -0.11%
NP -2,303 -2,018 -1,871 -2,839 -3,374 -4,799 -3,559 -6.99%
Tax Rate - - - - - - - -
Total Cost 2,303 2,168 1,871 3,116 3,798 5,046 3,858 -8.23%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin 0.00 -1,345.33 0.00 -1,024.91 -795.75 -1,942.91 -1,190.30 -
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS -2.68 -2.96 -3.14 -13.34 -23.15 -50.11 -44.87 -37.46%
EPS Diluted -2.68 -2.96 -3.12 -13.34 -23.15 -50.11 -44.87 -37.46%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.